The Latest

Clinical Endocrinology Update (CEU) 2025, taking place online October 21-23, brings you the latest advances in hormone care through interactive sessions that focus on applying knowledge directly to your practice. This year’s program covers essential topics, including diabetes management, GLP-1 therapies, adrenal and pituitary disorders, bone and calcium health, reproductive care, and more. Learn from leading experts and apply their insights to your day-to-day work. The program includes interactive real-time chat, where speakers address audience questions, while selected sessions feature a live bonus video for an even more dynamic and engaging experience.

Become a member of the Endocrine Society to stay on top of the latest news, cutting-edge research, and best practices in endocrinology. Gain immediate access to all our exclusive member benefits from now until December 31, 2026. Take advantage of the largest discount of the year when you join by Tuesday, September 30.

After seven years, we have reached our 100th episode! For this, we talk about growth hormone deficiency, about causes, prevalence, why some types may become permanent, available treatments, and the importance of adherence to treatment plans. Host Aaron Lohr talks with Sandro Loche, MD, of Bambino Gesù Children’s Hospital in Rome, Italy. Recently, Dr. Loche and colleagues presented research at ENDO 2025 in San Francisco titled, “Adherence to GH Treatment in the Transition Age: A Prospective Study.”

Eager to explore ground-breaking research into thyroid hormone receptors? Check out the new collection from Endocrinology. With the latest insights on thyroid hormone function and regulation, browse this curated collection now.

This book and eBook presents forty-one cases encompassing medical vignettes, practice gaps, and key learning points. Each case includes expert analysis, diagnostic reasoning, and treatment strategies from leaders in endocrinology, diabetes, and metabolism. Strengthen your clinical skills and earn 30.0 AMA PRA Category 1 Credits™ and 30 ABIM MOC points.

Amid growing global recognition of the hazards posed by endocrine-disrupting chemicals (EDCs), JES is a leader in publishing research on the broader consequences of EDCs for health, with an open access publication model. Submit today.

Do subclinical hyper- and hypothyroidism impact cardiovascular outcomes by affecting blood pressure, lipids, and other risk factors? Find out more in this episode!

Interested in staying informed with the latest endocrinology research? Follow @EndoSocJournals for top-quality articles from #JCEM, #Endocrinology, #JES, and #EndocrineReviews.